Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Maintenance Treatment of Schizophrenia. Show all posts
Showing posts with label Maintenance Treatment of Schizophrenia. Show all posts
Wednesday, November 29, 2017

Allergan Receives FDA Approval for Vraylar (cariprazine) in the Maintenance Treatment of Schizophrenia

›
In continuation of my update on Cariprazine Allergan plc (NYSE: AGN)  announced that the U.S. Food and Drug Administration (FDA) has...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.